---
title: Swiss BioQuant AG vs Sword Bio
slug_a: swissbioquant
slug_b: swordbio
site: cro
review_signal_gate: closed
canonical_path: /compare/swissbioquant/swordbio
generated_by: BioBM Editorial AI
---

# Swiss BioQuant AG vs Sword Bio

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Swiss BioQuant AG (swissbioquant) is listed for cro. Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.

Services: 6. Modalities: 6. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sword Bio (swordbio) is listed for cro. Bioanalytical CRO offering ligand binding assay development, PK, immunogenicity (ADA and NAb), and custom biomarker assays under non-GLP, spirit-of-GLP, and GLP conditions. Supports clients from discovery through clinical Phase IV.

Services: 5. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.